Predictive biomarkers of COVID-19 impact in renal transplant patients: an exploratory proteomic and cytokine analysis - Takeaways - MDSpire

Predictive biomarkers of COVID-19 impact in renal transplant patients: an exploratory proteomic and cytokine analysis

  • By

  • Ayodele Alaiya

  • Maha Al-Mozaini

  • Zakia Shinwari

  • Abdulaziz Alzayed

  • Ibtihaj Alsharif

  • Rabab Allam

  • Razan Bakheet

  • Layla Alharbi

  • Fahad Ojab Alotaibi

  • Jumana Idris

  • Dalia A. Obeid

  • Abeer Alshukairi

  • Marcela Márquez-Méndez

  • Ricardo M. Cerda-Flores

  • Hamad A. Almojalli

  • June 12, 2026

  • 0 min

Share

  • 1

    Renal transplant patients receiving immunomodulatory therapy are at increased risk of severe COVID-19 complications.

  • 2

    Cytokine levels significantly differed between healthy controls and COVID-19-affected renal transplant patients.

  • 3

    Eighteen altered protein targets were identified, with eight proteins potentially serving as biomarkers for COVID-19 risk in renal transplant patients.

  • 4

    Cytokine expression varied according to disease severity in COVID-19-affected renal transplant patients.

  • 5

    The study's small sample size and focus on surviving patients limit the generalizability of the findings.

Original Source(s)

Predictive biomarkers of COVID-19 impact in renal transplant patients: an exploratory proteomic and cytokine analysis

  • by Ayodele Alaiya, Maha Al-Mozaini, Zakia Shinwari, Abdulaziz Alzayed, Ibtihaj Alsharif, Rabab Allam, Razan Bakheet, Layla Alharbi, Fahad Ojab Alotaibi, Jumana Idris, Dalia A. Obeid, Abeer Alshukairi, Marcela Márquez-Méndez, Ricardo M. Cerda-Flores, Hamad A. Almojalli

  • June 12, 2026

Related Content